NOT KNOWN FACTUAL STATEMENTS ABOUT OTAMIXABAN

), aids to elucidate why KIF15 has the capacity to facilitate resistance to Eg5 inhibitors in vivo. MT gliding driven by each of those mitotic motors was arrested only when they ended up independently inhibited, lending help to the proposal that a mixture drug therapy focusing on these motors could be a workable strategy for beating chemotherapeuti